BiotechTube
Hexagon Pharma

Hexagon Pharma

Stockholm, Sweden· Est.
hexagon.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Hexagon Pharma is a long-established Swedish player offering specialized solutions in pharmaceutical manufacturing and digital health. Its business model appears to be service-oriented, providing technologies and platforms to streamline drug development and production for other companies. Operating as a private entity, it leverages its expertise in drug delivery systems and digital tools to serve the pharmaceutical sector, though specific pipeline details and financials are not publicly disclosed.

Drug DeliveryDigital Health

Technology Platform

Integrated drug delivery systems and digital health technologies (e.g., manufacturing software, data analytics) for pharmaceutical production.

Opportunities

Growing demand for specialized contract manufacturing and digital solutions due to increasing complexity of new drug modalities (e.g., biologics, cell therapies).
The industry-wide shift towards Pharma 4.0 and smart manufacturing creates a significant market for integrated digital tools that improve efficiency and compliance.

Risk Factors

Revenue dependency on a limited client base and vulnerability to outsourcing budget cuts.
Intense competition from larger global CDMOs and specialized software firms requires continuous innovation.
Regulatory risks associated with providing GMP manufacturing services and compliant software to a highly regulated industry.

Competitive Landscape

Competes in the fragmented Contract Development and Manufacturing Organization (CDMO) market against large players like Lonza and Catalent, as well as niche specialists. In digital health for pharma manufacturing, faces competition from enterprise software giants (e.g., Siemens, SAP) and dedicated life sciences software vendors.

More companies in Sweden →